showed a trendP = 0.06
Patients with fatigue (grades ≥3) showed a trend towards reduced survival (breast cancer-specific survival: HR = 1.17; 95 % CI, 0.99–1.37; P = 0.06).
Patients with fatigue (grades ≥3) showed a trend towards reduced survival (breast cancer-specific survival: HR = 1.17; 95 % CI, 0.99–1.37; P = 0.06).
Neutropenia, fatigue, anaemia, combined haematological toxicity and constipation were nominally significant ( P <0.1) for either BCSS or RFS (or both) on univariable analysis (Table 2 ).